Clinical Trials Sponsored by Direct MS-Proactive Charity
Total 1 results
-
University of TorontoMultiple Sclerosis Society of Canada; Direct MS-Proactive CharityCompletedMultiple SclerosisCanada
Sponsors and Collaborators
- University Centre for Chronic Diseases Dekkerswald, Groesbeek, NL
- Fondren Orthopedic Group L.L.P.
- The Fifth Affiliated Hospital of Zunyi Medical College
- Rui-hua Xu, MD, PhD
- Diego Hernan Giunta, MD
- Norsk Proteinintolerance, Norway
- University Medical Center Goettingen
- San MediTech(Huzhou)Co.,Ltd.
- Caritas Freetown
- Elim Pediatric Pharmaceuticals Inc.
- Donders Institute for Brain, Cognition and Behavior
- Celtaxsys Aus Pty Limited
- ProteoSys AG
- AMTC & Associates
- Societa Italiana di Endoscopia Digestiva
- Alberta Children's Hospital, Calgary, Canada
- Ilustre Colegio Profesional de Fisioterapeutas de la Comunidad de Madrid
- Victor Montori
- CRMBM-CEMEREM
- Cardresearch
- View Full List
Medical Conditions
- Malignant Ascites Due to Epithelial Carcinoma
- Stereotactic Radioablation for Ventricular Tachycardia
- Spermatogenesis Arrest
- Fever, Sweats, and Hot Flashes
- Non-compressible Torso Hemorrhage
- Orbital Tumor
- Normal Diameter of Optic Nerve
- Lymphedema of Arm
- Auditory Hallucination, Verbal
- Gynecologic Cancer
- Atrial Fibrillation, Postoperative
- Postcomatose Unawareness State
- Prostate Cancer Recurrent
- Non-dystrophic Myotonias
- Disturbance of Activity and Attention
- Fibromyalgia Syndrome, Primary
- Tube Disorders Eustachian
- Plasmodium Falciparum Malaria (Drug Resistant)
- Analgesics, Antipyretics, and Antirheumatics Causing Adverse Effects in Therapeutic Use
- Tularaemia
- View Full List
Drug Interventions
- Enzalutamide, Abiraterone
- CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose)
- Epimedium Prenylflavonoids Extract
- Oxycodone, fentanyl
- Cytarabine ARA-C
- Topotecan
- Atezolizumab
- Lamivudine
- Cetrorelix 78 mg + 78 mg
- Mupirocin Calcium
- PF-00868554
- Insulin
- SERETIDE Diskus
- Flibanserin 100 mg dose every evening
- Indoximod
- HB-202 / HB-201 alternating intravenous administration + standard of care regimen including pembrolizumab.
- Bortezomib/dexamethasone
- Polyethylene glycol 3350
- Methotrexate
- Ruxolitinib
- View Full List
CROs by country
- Contract Research Organizations in Angola
- Contract Research Organizations in Bosnia & Herzegovina
- Contract Research Organizations in Cyprus
- Contract Research Organizations in Hungary
- Contract Research Organizations in Ireland
- Contract Research Organizations in Japan
- Contract Research Organizations in Macedonia
- Contract Research Organizations in Mauritania
- Contract Research Organizations in Panama
- Contract Research Organizations in Romania
- Contract Research Organizations in Saudi Arabia
- Contract Research Organizations in Sri Lanka
- Contract Research Organizations in Switzerland
- CRO list by country